CNE100005XJ7
CNE100005XJ7
SHANGHAI ALLIST PHARMACEUTICALS
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 |
|---|---|---|---|
Market & Enterprise Value | |||
Market Cap | 37.13B EUR | 49.14B EUR | 43.2B EUR |
Enterprise Value | 32.89B EUR | 48.04B EUR | 41.86B EUR |
Valuation Multiples | |||
Trailing P/E | 13.89x | 17.84x | 19.11x |
Forward P/E | 11.35x | -- | -- |
Price to Sales | 6.05x | 8.12x | 7.98x |
Price to Book | 4.39x | 5.81x | 5.58x |
EV/Revenue | 5.36x | 7.94x | 7.73x |
EV/EBITDA | 12.14x | 15.09x | 16.13x |
Price to FCF (P/FCF) | 23.92x | 18.52x | 20.49x |
EV/FCF | 21.19x | 18.11x | 19.86x |
FCF Yield | 4.18% | 5.4% | 4.88% |